In patients with metastatic non–clear cell renal cell carcinoma, the combination of cytoreductive nephrectomy and systemic therapy confers better survival, with respect to single treatments alone or no treatment.

Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non–clear Cell Renal Cell Carcinoma Patients

Rosiello G.;Briganti A.;
2021-01-01

Abstract

In patients with metastatic non–clear cell renal cell carcinoma, the combination of cytoreductive nephrectomy and systemic therapy confers better survival, with respect to single treatments alone or no treatment.
2021
Cytoreductive nephrectomy
Histological subtypes
Metastases
Non–clear cell renal cell carcinoma
Overall mortality
Systemic therapy
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/108556
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 17
social impact